Des-Arg(9) bradykinin as a causal metabolite for autism spectrum disorder

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

825

Figures (1-4)

Tables (1-4)

Sum=1049

Publishing Process of This Article

Item

Count

Browse

452

Download

242

Sum=694

Jan 19, 2024 (publication date) through Jun 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Jan 19, 2024; 14(1): 88-101
Published online Jan 19, 2024. doi: 10.5498/wjp.v14.i1.88

Table 1 Details of the genome-wide association studies consortiums

Variable	Ancestry	Ref.	Sample size	Sex	Data download
Metabolite	European	Shin et al[20], 2014	7824	Mixed	http://metabolomics.helmholtz-muenchen.de/gwas/
Autism spectrum disorder	European	Grove et al[21], 2017	Cases = 18381; Controls = 27969	Mixed	https://doi.org/10.6084/m9.figshare.14671989

Citation: Huang ZY, Lyu ZP, Li HG, You HZ, Yang XN, Cha CH. Des-Arg(9) bradykinin as a causal metabolite for autism spectrum disorder. World J Psychiatry 2024; 14(1): 88-101
URL: https://www.wjgnet.com/2220-3206/full/v14/i1/88.htm
DOI: https://dx.doi.org/10.5498/wjp.v14.i1.88